Shri Khemisati Pharmapack Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 31-12-2024
- Paid Up Capital ₹ 1.72 Cr
as on 31-12-2024
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 31-12-2024
- Satisfied Charges ₹ 9.80 Cr
as on 31-12-2024
- Revenue %
(FY 2022)
- Profit -13.58%
(FY 2022)
- Ebitda 98.21%
(FY 2022)
- Net Worth -0.03%
(FY 2022)
- Total Assets -0.00%
(FY 2022)
About Shri Khemisati Pharmapack
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.72 Cr.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹9.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santkumar Tibrewala, Manish Tibrewala, and Asha Tibrewala serve as directors at the Company.
- CIN/LLPIN
U25111MH1994PLC079161
- Company No.
079161
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shri Khemisati Pharmapack?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santkumar Tibrewala  | Director | 23-Jun-1994 | Current |
| Manish Tibrewala | Director | 23-Jun-1994 | Current |
| Asha Tibrewala | Director | 03-May-2019 | Current |
Financial Performance of Shri Khemisati Pharmapack.
Shri Khemisati Pharmapack Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 13.58% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Khemisati Pharmapack?
In 2021, Shri Khemisati Pharmapack had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Gujarat Industrial Investment Corporation Ltd Creation Date: 26 Jun 1995 | ₹2.50 Cr | Open |
State Bank Of India Creation Date: 24 Jan 2008 | ₹7.70 Cr | Satisfied |
State Bank Of India Creation Date: 01 Dec 1998 | ₹6.00 M | Satisfied |
How Many Employees Work at Shri Khemisati Pharmapack?
Unlock and access historical data on people associated with Shri Khemisati Pharmapack, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Khemisati Pharmapack, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Khemisati Pharmapack's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
